quantitative flow ratio, percutaneous coronary intervention, major adverse cardiac and cerebrovascular events, incremental cost-effectiveness ratio, quality-adjusted life-years
IL-1R2; IL-17RA; NLRP3 inflammasome; ischemia/reperfusion injury; pyroptosis; cardiomyocyte apoptosis
Thyroid hormone, Peripheral sensitivity, Contrast-induced acute kidney injury, FT3/FT4
adventitial delivery, miR-145, intimal hyperplasia, peptide hydrogels, injectable, self-assembling
heart failure (HF), biomarker, transcriptome, machine learning, molecular docking